Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > Report on sedar

<< Previous

Bullboard Posts

Next >>

Comment by Infinityon Nov 26, 2024 2:23am

134 Views

Post# 36330461

RE:RE:RE:RE:RE:Report on sedar

Most Directors and senior Management have been awarded stock options totalling 4.2 Million in 2015, +2.8 Million in 2017+10.0 Million in 2019, + 7.8 Million in 2022. I may be missing a few other awarded stock options. Some have expiry date of 5 years, may not be good anymore. These are essentially freebies they do not have to participate in any PP or risk their money!!

<< Previous

Bullboard Posts

Next >>

How one company is disrupting PoC testing